Abstract: Medical devices made with coatings made from recombinant spider silk proteins are disclosed. Methods to make the devices are also disclosed. Methods for adhering objects to one another using recombinant spider silk proteins are also disclosed.
Type:
Application
Filed:
January 26, 2017
Publication date:
January 10, 2019
Applicant:
Utah State University
Inventors:
Randolph V. Lewis, Justin A. Jones, Thomas Ian Harris, Danielle Gaztambide, Breton A. Day
Abstract: Embodiments of a system and method for identifying malware tasks using a controlled environment to run malicious software to generate analysis reports, a parser to extract features from the analysis reports and a cognitively inspired learning algorithm to predict tasks associated with the malware are disclosed.
Type:
Grant
Filed:
June 17, 2016
Date of Patent:
January 8, 2019
Assignees:
Arizona Board of Regents on Behalf of Arizona State University, Carnegie Mellon University
Inventors:
Paulo Shakarian, Eric Nunes, Casey Buto, Christian Lebiere, Robert Thomson, Stefano Bennati
Abstract: B/N Lewis pairs have been discovered to catalyze rapid epimerization of meso-lactide (LA) or LA diastereomers quantitatively into rac-LA. The obtained rac-LA can be kinetically polymerized into poly(L-lactide) and optically resolved D-LA, with a high stereoselectivity factor kL/kD of 53 and an ee value of 91% at 50.6% monomer conversion, by a bifunctional chiral catalyst. The epimerization and enantioselective polymerization can be coupled into a one-pot process for transforming meso-LA directly into poly(L-lactide) and D-LA.
Type:
Grant
Filed:
September 2, 2016
Date of Patent:
January 8, 2019
Assignee:
Colorado State University Research Foundation
Abstract: A nanodevice composition including N-acetyl cysteine linked to a dendrimer, such as a PAMAM dendrimer or a multiarm PEG polymer, is provided. Also provided is a nanodevice for targeted delivery of a compound to a location in need of treatment. The nanodevice includes a PAMAM dendrimer or multiarm PEG polymer, linked to the compound via a disulfide bond. There is provided a nanodevice composition for localizing and delivering therapeutically active agents, the nanodevice includes a PAMAM dendrimer or multiarm PEG polymer and at least one therapeutically active agent attached to the PAMAM dendrimer or multiarm PEG polymer.
Type:
Grant
Filed:
September 4, 2014
Date of Patent:
January 8, 2019
Assignees:
Wayne State University, The United States of America as Represented by the Secretary, Department of Health and Human Service
Inventors:
Kannan Rangaramanujam, Sujatha Kannan, Roberto Romero, Raghavendra S. Navath, Hui Dai, Anupa R. Menjoge
Abstract: The present invention provides STING crystals. The present invention also provides STING modulators that interact with sites present in and/or defined by such crystals. The present invention also provides methods of making and using such crystals and modulators. Other aspects and/or features of the present invention will be apparent to those skilled in the art, reading the present specification.
Type:
Grant
Filed:
July 31, 2014
Date of Patent:
January 8, 2019
Assignees:
Memorial Sloan-Kettering Cancer Center, The Rockefeller University, Rutgers, The State University of New Jersey, University of Bonn
Inventors:
Dinshaw J. Patel, Thomas Tuschl, Roger Jones, Gunther Hartmann, Winfried Barchet, Thomas Zillinger, Weiyi Wang, Pu Gao, Liang Deng, Manuel Ascano, Jr.
Abstract: A method to generate siRNAs in vivo is described, as are constructs and compositions useful in the method. The method does not depend on the use of DNA or synthetic constructs that contain inverted duplications or dual promoters so as to form perfect or largely double-stranded RNA. Rather, the method depends on constructs that yield single-stranded RNA transcripts, and exploits endogenous or in vivo-produced miRNAs or siRNAs to initiate production of siRNAs. The miRNAs or siRNAs guide cleavage of the transcript and set the register for production of siRNAs (usually 21 nucleotides in length) encoded adjacent to the initiation cleavage site within the construct. The method results in specific formation of siRNAs of predictable size and register (phase) relative to the initiation cleavage site. The method can be used to produce specific siRNAs in vivo for inactivation or suppression of one or more target genes or other entities, such as pathogens.
Abstract: A sensor for hydrocarbons uses a waveguide with a first cladding layer, a second cladding layer with a measurement region with hydrophobic measurement material, and a core between the first and second cladding layers. Light is coupled into the waveguide. The measurement material is exposed to the hydrocarbon allowing the hydrocarbon to diffuse into it and change refractive index of the material, which changes intensity of light evanescently coupled through the first cladding layer. Light coupled through the first cladding layer is measured to determine exposure of the sensor to the hydrocarbons.
Type:
Grant
Filed:
December 19, 2017
Date of Patent:
January 8, 2019
Assignee:
Colorado State University Research Foundation
Abstract: The present invention provides a novel assay that allows high-throughput screening of chemical compounds for the inhibition of binding between EF-Tu and tRNA.
Type:
Grant
Filed:
October 31, 2014
Date of Patent:
January 8, 2019
Assignee:
Rutgers, The State University of New Jersey
Abstract: Novel methods for the in vivo production of phenol from renewable substrates using a recombinant microorganism (FIG. 1). Additionally, methods for the in vivo production of catechol and cis,cis-muconic acid from renewable substrates using a recombinant microorganism are disclosed. A host cell expresses at least one gene encoding a polypeptide that possesses isochorismate synthase activity, at least one gene encoding a polypeptide that possesses isochorismate pyruvate lyase activity, and at least one gene encoding a polypeptide that possesses salicylic acid decarboxylase activity. In the case of catechol, the host cell must additionally express at least one gene encoding a polypeptide that possesses phenol 2-monooxygenase activity. In the case of cis,cis-muconic acid, the host cell must additionally express at least one gene encoding a polypeptide that possesses phenol 2-monooxygenase activity and at least one gene encoding a polypeptide that possesses catechol-1,2-dioxygenase activity.
Type:
Grant
Filed:
August 12, 2014
Date of Patent:
January 8, 2019
Assignee:
Arizona Board of Regents on behalf of Arizona State University
Inventors:
David Nielsen, Shawn Pugh, Brian Thompson
Abstract: Platinum (II) and palladium (II) complexes of Formulas A and B and iridium (III) complexes of Formula C having azepine functional groups and their analogs as emitters for full color displays and lighting applications.
Type:
Grant
Filed:
June 16, 2017
Date of Patent:
January 8, 2019
Assignee:
Arizona Board of Regents on behalf of Arizona State University
Abstract: Oral compositions and methods of use thereof are provided herein. The oral compositions comprise a first component comprising at least one Eh-raising compound and a pharmaceutically acceptable carrier, and a second component comprising at least one zinc compound, an anti-microbial agent and a pharmaceutically acceptable carrier.
Type:
Application
Filed:
September 6, 2018
Publication date:
January 3, 2019
Applicant:
The Research Foundation for the State University o f New York
Inventors:
Marvin COHEN, Susanne COHEN, Robert G. FLYNN
Abstract: A Quaternary Mg—Zn—Ca-based alloy and a heat treatment process for producing bioresorbable bone fixation implants are described thereof. The mechanical and biocorrosion properties of the fabricated Mg-based alloy were improved by combining careful selection of the alloy's chemical composition and subsequent post-shaping process (heat treatments). Heat treatment process is more privileged especially after fabricating the part into its final shape such as in additive manufacturing (3D-printing) and powder metallurgy. In this way, it is possible to produce biocompatible, strong and less corrosive patient-specific bone fixation hardware. Also, such heat-treated Mg—Zn—Ca-based parts can be further coated with various types of biocompatible ceramic coatings for slower and more tailored biocorrosion rates.
Type:
Application
Filed:
December 21, 2016
Publication date:
January 3, 2019
Applicants:
The University of Toledo, Ohio State University
Inventors:
Hamdy IBRAHIM, Mohammad ELAHINIA, Howard David DEAN
Abstract: This invention provides an attenuated virus comprising a modified viral genome engineered to containing multiple nucleotide substitutions that reduce the codon pair bias of a virus protein encoding sequence relative to a first host while the codon pair bias relative to a second host is not substantially reduced. In another embodiment, the invention provides an attenuated virus comprising modified viral genome engineered to containing multiple nucleotide substitutions that reduce the codon pair bias of a virus protein-encoding sequence relative to a first host and a second host. The attenuated virus may be used in a vaccine composition for inducing a protective immune response in a subject. The invention also provides a method of synthesizing the attenuated virus.
Type:
Application
Filed:
September 8, 2015
Publication date:
January 3, 2019
Applicant:
The Research Foundation for The State University of New York
Inventors:
Eckard Wimmer, Steffen Mueller, Bruce Futcher, Sam Shen, Charles Stauft, Charles Ward
Abstract: Provided herein is a polymeric material comprising a polymer host; and a guest molecule comprising a glycosaminoglycan; wherein the guest molecule is disposed within the polymer host, and wherein the guest molecule is covalently bonded to at least one other guest molecule. In some embodiments, the polymer host comprises a silicone-based polymer. In other embodiments, the glycosaminoglycan is chosen from hyaluronic acid and derivatives thereof.
Type:
Grant
Filed:
September 10, 2014
Date of Patent:
January 1, 2019
Assignee:
Colorado State University Research Foundation
Inventors:
Susan P. James, Travis S. Bailey, Ketul C. Popat, David A. Prawel, Jackson T. Lewis, Richard L. Koch
Abstract: Disclosed is a radio frequency (RF) power calorimeter having a load electrically coupled to a RF input, a variable low-frequency power source electrically coupled to the load and configured to apply low-frequency bias to the load. The RF power calorimeter includes a thermal medium thermally coupled to the load. Additionally, the RF power calorimeter includes an outlet temperature sensor thermally coupled to the thermal medium, the outlet temperature sensor being positioned to measure the temperature of the thermal medium due to heating by the load. The RF power calorimeter also has circuitry configured to use temperature measurements of the thermal medium in thermal contact with an RF load in combination with the low-frequency bias to measure average power of an RF source electrically coupled to the RF input. Also disclosed in a method of measuring RF power using the RF power calorimeter.
Type:
Grant
Filed:
February 20, 2014
Date of Patent:
January 1, 2019
Assignees:
Bird Technologies Group Inc., The Research Foundation for the State University of New York
Inventors:
Joel D. Meltzer, Albert H. Titus, Bilel Neji, Jing Xu
Abstract: A microfluidic apparatus, systems and methods for microfluidic crystallization based on gradient mixing. In one embodiment, the apparatus includes (a) a first layer, (b) a plurality of first channels and a plurality of vacuum chambers both arranged in the first layer, where the plurality of vacuum chambers are each coupled to at least one of the first channels, (c) a membrane having first and second surfaces, where the first surface of the membrane is coupled to the first layer, (d) a second layer coupled to the second surface of the membrane, (e) a plurality of wells and a plurality of second channels both arranged in the second layer, where the wells are each coupled to at least one of the plurality of second channels and (f) a plurality of barrier walls each disposed in the plurality of second channels and arranged opposite to one of the plurality of vacuum chambers.
Type:
Grant
Filed:
September 17, 2015
Date of Patent:
January 1, 2019
Assignee:
Arizona Board of Regents on behalf of Arizona State University
Abstract: Forming a metal oxide by treating an acidic solution containing a metal to yield a precursor in the form of a semi-liquid, semi-solid or solid, and treating the precursor to yield a product including the metal oxide. An organic or inorganic component may be combined with the precursor to yield a second semi-liquid, semi-solid or solid. The product may be treated to yield a new material. In some cases, the metal oxide has an empirical formula HxM2A1y-A2z, where M represents a transition metal or any combination of transition metals in Groups 3-12; A1 is a first oxyanion; A2 is a second oxyanion; 0?x?3; 0?y?3; 0?z?3; and y+z>0.
Type:
Grant
Filed:
June 12, 2014
Date of Patent:
January 1, 2019
Assignee:
Arizona Board of Regents on behalf of Arizona State University
Inventors:
Dong-Kyun Seo, Daniel Mieritz, Candace Chan, Ran Zhao
Abstract: Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. The implanted stimulation device includes a physiological sensor for monitoring the patient's response to the neurostimulation therapy on an ambulatory basis over extended periods of time and a control system for adjusting stimulation parameters to maintain stimulation in the neural fulcrum zone based on detected changes in the physiological response to stimulation.
Type:
Grant
Filed:
November 6, 2017
Date of Patent:
January 1, 2019
Assignees:
Cybertronics, Inc., East Tennessee State University
Inventors:
Imad Libbus, Badri Amurthur, Bruce H. KenKnight, Jeffrey L. Ardell
Abstract: Soluble polyphosphides were successfully generated in a number of organic solvents by a reaction between shelf-stable red phosphorus and potassium ethoxide or other nucleophilic activators. The species were identified by 31P-NMR in solution. The reaction was scaled up to gram quantities by using a flow-chemistry process.
Type:
Grant
Filed:
February 9, 2017
Date of Patent:
January 1, 2019
Assignee:
The Florida State University Research Foundation, Inc.
Inventors:
Michael Shatruk, David Tyler McQuade, Alina Dragulescu-Andrasi, Levi Zane Miller, Chongin Pak
Abstract: Snapshot Isolation (SI) is an established model in the database community, which permits write-read conflicts to pass and aborts transactions only on write-write conflicts. With the Write Skew Anomaly (WSA) correctly eliminated, SI can reduce the occurrence of aborts, save the work done by transactions, and greatly benefit long transactions involving complex data structures. Embodiments include a multi-versioned memory subsystem for hardware-based transactional memory (HTM) on the GPU, with a method for eliminating the WSA on the fly, and incorporates SI. The GPU HTM can provide reduced compute time for some compute tasks.
Type:
Application
Filed:
June 22, 2018
Publication date:
December 27, 2018
Applicant:
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College